CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not(671 views) Neve Polimeno M, Ierano C, D'Alterio C, Simona Losito N, Napolitano M, Portella L, Scognamiglio G, Tatangelo F, Maria Trotta A, Curley S, Costantini S, Liuzzi R, Izzo F, Scala S
Cell Mol Immunol (ISSN: 1672-7681), 2014 Nov 3; 12(4): 474-482.
Keywords: Cxcl12, Hepatocellular Carcinoma, Prognosis, Chemokine Receptor Cxcr4, Messenger Rna, Plerixafor, Article, Cancer Grading, Cancer Growth, Cancer Prognosis, Cancer Staging, Cancer Survival, Cell Invasion, Cell Migration, Human, Human Cell, Immunocytochemistry, Immunohistochemistry, Liver Cell Carcinoma, Major Clinical Study, Overall Survival, Progression Free Survival, Protein Expression, Protein Function, Protein Localization, Tumor Volume, Upregulation, Adult, 80 And Over, Immunology, Metabolism, Mortality, Disease-Free Survival, Female, Gene Expression Regulation, Neoplastic, Hep G2 Cells, Liver Neoplasms, Middle Aged, Neoplasm Proteins, Biosynthesis, Survival Rate, Cxcr4 Protein, Cxcr7 Protein, Tumor Protein, Disease Free Survival, Hep-G2 Cell Line, Liver Tumor, Very Elderly,
Affiliations: *** IBB - CNR ***
Oncological Immunology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Giovanni Pascale"-IRCCS-ITALIA, Naples, Italy.
Pathology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Giovanni Pascale"-IRCCS-ITALIA, Naples, Italy.
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
CROM-Centro Ricerche Oncologiche Mercogliano, Mercogliano (AV), Italy.
Institute of Biostructure and Bioimaging (IBB) of the Italian National Research Council, Naples, Italy.
Hepato-Biliary Surgery Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Giovanni Pascale"-IRCCS-ITALIA, Naples, Italy.
References: Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Thun, M.J., Cancer statistics (2007 (2007) CA Cancer J Clin, 57, pp. 43-6
Malhi, H., Gores, G.J., Cellular and molecular mechanisms of liver injury (2008) Gastroenterology, 134, pp. 1641-1654
Wald, O., Weiss, I.D., Galun, E., Peled, A., Chemokines in hepatitis C virus infection: Pathogenesis, prognosis and therapeutics (2007) Cytokine, 39, pp. 50-62
Huang, F., Geng, X.P., Chemokines and hepatocellular carcinoma (2010) World J Gastroenterol, 16, pp. 1832-1836
Li, W., Gomez, E., Zhang, Z., Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma (2007) J Exp Clin Cancer Res, 26, pp. 527-533
Liu, H., Pan, Z., Li, A., Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells (2008) Cell Mol Immunol, 5, pp. 373-378
Schimanski, C.C., Bahre, R., Gockel, I., Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4 (2006) Br J Cancer, 95, pp. 210-217
Xiang, Z.L., Zeng, Z.C., Tang, Z.Y., Fan, J., Zhuang, P.Y., Liang, Y., Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival (2009) BMC Cancer, 9, p. 176
Xiang, Z., Zeng, Z., Tang, Z., Fan, J., Sun, H., Wu, W., Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome (2009) Cancer J, 15, pp. 519-525
Monnier, J., Boissan, M., Lhelgoualch, A., CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells (2012) Eur J Cancer, 48, pp. 138-148
Zheng, K., Li, H.Y., Su, X.L., Wang, X.Y., Tian, T., Li, F., Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells (2010) J Exp Clin Cancer Res, 29, p. 31
Balabanian, K., Lagane, B., Infantino, S., The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes (2005) J Biol Chem, 280, pp. 35760-35766
Miao, Z., Luker, K.E., Summers BC CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-Associated vasculature (2007) Proc Natl Acad Sci USA, 104, pp. 15735-15740
Wang, J., Shiozawa, Y., Wang, J., The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer (2008) J Biol Chem, 283, pp. 4283-4294
Tarnowski, M., Grymula, K., Reca, R., Regulation of expression of stromalderived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas (2010) Mol Cancer Res, 8, pp. 1-14
Hattermann, K., Held-Feindt, J., Lucius, R., The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects (2010) Cancer Res, 70, pp. 3299-3308
Müller, A., Homey, B., Soto, H., Involvement of chemokine receptors in breast cancer metastasis (2001) Nature, 410, pp. 50-56
Murphy, P.M., The molecular biology of leukocyte chemoattractant receptors (1994) Annu Rev Immunol, 12, pp. 593-633
Taichman, R.S., Cooper, C., Keller, E.T., Pienta, K.J., Taichman, N.S., McCauley, L.K., Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone (2002) Cancer Res, 62, pp. 1832-1837
Burns, J.M., Summers, B.C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development (2006) J Exp Med, 203, pp. 2201-2213
Thelen, M., Thelen, S., CXCR7, CXCR4 and CXCL12, an eccentric trio (2008) J Neuroimmunol, 198, pp. 9-13
Sierro, F., Biben, C., Martínez-Muñoz, L., Mellado, M., Ransohoff, R.M., Li, M., Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 (2007) Proc Natl Acad Sci USA, 104, pp. 14759-14764
Grymula, K., Tarnowski, M., Wysoczynski, M., Drukala, J., Barr, F.G., Ratajczak, J., Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas (2010) Int J Cancer, 127, pp. 2554-2568
Hou, K.L., Hao, M.G., Bo, J.J., Wang, J.H., CXCR7 in tumorigenesis and progression (2010) Chin J Cancer, 29, pp. 456-459
Zabel, B.A., Wang, Y., Lewén, S., Berahovich, R.D., Penfold, M.E., Zhang, P., Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands (2009) J Immunol, 183, pp. 3204-3211
Iwakiri, S., Mino, N., Takahashi, T., Sonobe, M., Nagai, S., Okubo, K., Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage i nonsmall cell lung cancer (2009) Cancer, 115, pp. 2580-2593
Dalterio, C., Consales, C., Polimeno, M., Franco, R., Cindolo, L., Portella, L., Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer (2010) Curr Cancer Drug Targets, 10, pp. 772-781
Portella, L., Vitale, R., De Luca, S., Dalterio, C., Ieranò, C., Napolitano, M., Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases (2013) PLoS One, 13, p. 8
Mitra, P., De, A., Ethier, M.F., Mimori, K., Kodys, K., Shibuta, K., Loss of chemokine SDF-1alpha-mediated CXCR4 signalling and receptor internalization in human hepatoma cell line HepG2 (2001) Cell Signal, 13, pp. 311-319
Fedyk, E.R., Ryan, D.H., Ritterman, I., Springer, T.A., Maturation decreases responsiveness of human bone marrow B lineage cells to stromalderived factor 1 (SDF-1 (1999) J Leuk Biol, 66, pp. 667-673
Honczarenko, M., Douglas, R.S., Mathias, C., Lee, B., Ratajczak, M.Z., Silberstein, L.E., SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells (1999) Blood, 94, pp. 2990-2998
Sutton, A., Friand, V., Brulé-Donneger, S., Chaigneau, T., Ziol, M., Sainte-Catherine, O., Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion (2007) Mol Cancer Res, 5, pp. 21-33
Kim, S.W., Kim, H.Y., Song, I.C., Jin, S.A., Lee, H.J., Yun, H.J., Cytoplasmic trapping of CXCR4 in hepatocellular carcinoma cell lines (2008) Cancer Res Treat, 40, pp. 53-61
Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska-Wieczorek, A., Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: Pivotal role of the SDF-1-CXCR4 axis (2005) Stem Cells, 23, pp. 879-894
Xue, T.C., Han, D., Chen, R.X., Zou, J.H., Wang, Y., Tang, Z.Y., High expression of CXCR7 combined with Alpha fetoprotein in hepatocellular carcinoma correlates with extrahepatic metastasis to lung after hepatectomy (2011) Asian Pac J Cancer Prev, 12, pp. 657-663
Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F., Lagane, B., CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling (2009) Blood, 113, pp. 6085-6093
Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C.M., Gerard, N.P., Betaarrestin-but notGprotein-mediatedsignaling by the decoyreceptor CXCR7 (2010) Proc Natl Acad Sci USA, 107, pp. 628-632
Naumann, U., Cameroni, E., Pruenster, M., Mahabaleshwar, H., Raz, E., Zerwes, H.G., CXCR7 functionsas a scavenger for CXCL12 and CXCL11 (2010) PLoS One, 5, p. e9175
Boldajipour, B., Mahabaleshwar, H., Kardash, E., Reichman-Fried, M., Blaser, H., Minina, S., Control of chemokine-guided cell migration by ligand sequestration (2008) Cell, 132, pp. 463-473
Luker, K.E., Lewin, S.A., Mihalko, L.A., Schmidt, B.T., Winkler, J.S., Coggins, N.L., Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells (2012) Oncogene, 31, pp. 4750-4758
De Caillot, F.M., Kazmi, M.A., Lin, Y., Ray-Saha, S., Sakmar, T.P., Sachdev, P., CXCR7/CXCR4 heterodimer constitutive lyrecruits beta-Arrestin to enhance cell migration (2011) J Biol Chem, 286, pp. 32188-32197
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
Hepatocellular carcinoma (HCC) is a heterogeneous disease with a poor prognosis and limited markers for predicting patient survival. Because chemokines and chemokine receptors play numerous and integral roles in HCC disease progression, the CXCR4-CXCL12-CXCR7 axis was studied in HCC patients. CXCR4 and CXCR7 expression was analyzed by immunohistochemistry in 86 HCC patients (training cohort) and validated in 42 unrelated HCC patients (validation cohort). CXCR4 levels were low in 22.1% of patients, intermediate in 30.2%, and high in 47.7%, whereas CXCR7 levels were low in 9.3% of patients, intermediate in 44.2% and high in 46.5% of the patients in the training cohort. When correlated to patient outcome, only CXCR4 affected overall survival (P=0.03). CXCR4-CXCL12-CXCR7 mRNA levels were examined in 33/86 patients. Interestingly, the common CXCR4-CXCR7 ligand CXCL12 was expressed at significantly lower levels in tumor tissues compared to adjacent normal liver (P=0.032). The expression and function of CXCR4 and CXCR7 was also analyzed in several human HCC cell lines. CXCR4 was expressed in Huh7, Hep3B, SNU398, SNU449 and SNU475 cells, whereas CXCR7 was expressed in HepG2, Huh7, SNU449 and SNU475 cells. Huh7, SNU449 and SNU475 cells migrated toward CXCL12, and this migration was inhibited by AMD3100/anti-CXCR4 and by CCX771/anti-CXCR7. Moreover, SNU449 and Huh7 cells exhibited matrix invasion in the presence of CXCL12 and CXCL11, a ligand exclusive to CXCR7. In conclusion, CXCR4 affects the prognosis of HCC patients but CXCR7 does not. Therefore, the CXCR4-CXCL12-CXCR7 axis plays a role in the interaction of HCC with the surrounding normal tissue and represents a suitable therapeutic target.Cellular & Molecular Immunology advance online publication, 3 November 2014; doi:10.1038/cmi.2014.102.
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
No results.
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not